Table 2 Baseline characteristics stratified by fatty fish consumption: the Tromsø study
From: Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study
Fatty fish servings, times per week | ||||
|---|---|---|---|---|
Baseline characteristics | < 1 n = 1841 | 1–1.9 n = 1518 | ≥2 n = 541 | p-trend |
Age, y | 60.3 (0.2) | 61.3 (0.2) | 63.6 (0.3) | < 0.0001 |
Male, % | 49.6 | 50.4 | 57.1 | 0.009 |
Higher education, %a | 18.2 | 19.9 | 18.3 | 0.6 |
Physical active, % | 23.2 | 23.0 | 24.4 | 0.7 |
BMI, kg/m2 | 25.9 (0.1) | 26.0 (0.1) | 26.1 (0.2) | 0.4 |
Total cholesterol, mmol/L | 6.77 (0.03) | 6.80 (0.03) | 6.77 (0.05) | 0.9 |
LDL cholesterol, mmol/L | 4.45 (0.03) | 4.48 (0.03) | 4.46 (0.05) | 0.8 |
HDL cholesterol, mmol/L | 1.55 (0.09) | 1.57 (0.01) | 1.56 (0.02) | 0.3 |
LDL/HDL ratio | 3.10 (0.03) | 3.09 (0.03) | 3.13 (0.05) | 0.9 |
Triglycerides, mmol/L | 1.69 (0.02) | 1.65 (0.03) | 1.63 (0.04) | 0.2 |
Systolic blood pressure, mmHg | 145.4 (0.5) | 145.1 (0.5) | 146.1 (0.9) | 0.7 |
Diastolic blood pressure, mmHg | 84.0 (0.3) | 83.6 (0.3) | 84.6 (0.5) | 0.7 |
Hypertension, % | 55.8 | 55.3 | 58.3 | 0.5 |
Current smoking, % | 30.7 | 32.0 | 35.7 | 0.04 |
Coffee consumption, cups/d | ||||
Boiled coffee | 3.1 (0.1) | 2.9 (0.1) | 3.1 (0.2) | 0.5 |
Other coffee | 2.7 (0.1) | 2.7 (0.1) | 2.7 (0.1) | 0.8 |
Diabetes, % | 2.1 | 2.9 | 2.9 | 0.2 |
Fish oil supplements, %b | 45.8 | 52.0 | 55.1 | < 0.0001 |
Antihypertensive medication, % | 11.0 | 9.1 | 11.5 | 0.7 |
Lipid-lowering medication, %c | 1.1 | 1.9 | 2.7 | 0.02 |
Leucocyte count, × 109/L | 6.86 (0.04) | 6.89 (0.05) | 7.05 (0.08) | 0.08 |
Monocyte count, × 109/L | 0.58 (0.004) | 0.59 (0.005) | 0.60 (0.008) | 0.3 |
Fibrinogen, g/L | 3.37 (0.02) | 3.38 (0.02) | 3.44 (0.04) | 0.1 |
logCRP, mg/L | 0.23 (0.03) | 0.26 (0.03) | 0.35 (0.05) | 0.04 |